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Individuals living in houses with a high radon concentration
have a significantly increased frequency of chromosomal
aberrations in peripheral lymphocytes, the a-dose being
delivered mainly by the radon daughter nuclides "’Po and
214PO. Some epidemiological and geographical studies have
suggested an association between a-particle exposure via
radon and the occurrence of leukaemia, brain tumours, and
kidney cancer, especially in children. 5
The presence of 210Po in vehicle exhausts may be unique in
terms of what is known of its carcinogenic potential at
environmental exposure levels. In our view it should be
added to the list of potential carcinogens from motor
vehicles to which the population is exposed.
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WHO’s current policies and plans for reform
SIR-In your Jan 28 editorial you make an ill-informed
attack on the World Health Organization. By coincidence,
your editorial appeared as the Executive Board of WHO
concluded one of its most constructive sessions in recent
years, during which it endorsed a wide range of important
reforms and helped to set its targets and priorities for the
future. No one from The Lancet attended any of the board’s
eleven working days.
Far from adopting "a fortress mentality, fighting bitterly to
retain the status quo and meanwhile allowing goodwill and
opportunities for revitalisation to slip away", WHO is
dedicating itself to radical change, to greater openness and
to closer relations with its partners in health. You seem out
of touch with WHO’s current policies and reforms, and
make sweeping and inaccurate assertions. For example, you
say "the mental and societal dimensions of health are
virtually ignored"-but WHO’s Division of Mental Health
made world headlines with a major 14-country study of
mental illness published in December, 1994, in the Journal
of the Arnerican Medical Association. Another example is,
"Appropriate respect for national sovereignty has been
overtaken by blind obeisance to narrow national wishes-eg,
the desire to avoid embarrassment, as in admitting that an
epidemic is underway". WHO intervened directly in the
plague outbreak in India last September. The Director-
General went to India, met the Prime Minister and Health
Minister, and set up in India an international team that
thoroughly investigated the outbreak and produced a full
report.
You say that WHO "remains essentially unaccountable",
but it is directly accountable to each and all of its 189
member states (whom you also describe as its "official
shareholders") through the Executive Board and the World
Health Assembly. The Board, in its discussions of the WHO
budget during the past two weeks, has shown that it has no
doubts of our accountability.
You omit recognition of some undisputed facts: that
WHO policies and activities result in the savings of millions
of lives a year, especially those of children in the developing
world (WHO had a key role in rapidly bringing under
control the deadly cholera epidemic among Rwandan
refugees in Zaire last year); that WHO is regarded world-
wide as the leading authority on health; and that the
standards it sets and maintains are the yardsticks by which
countries of the world measure their own health status.
WHO welcomes constructive criticism and responds
positively to it. Our new communications policy will support
such a dialogue. But it has become fashionable lately to
attack WHO, especially in the public health community,
without much apparent thought to the harm that this does
not merely to WHO, but also to all those we seek to serve.
Ilona Kickbusch,
Director of Health Promotion, Education and Communication
World Health Organization, CH 1211 Geneva 27, Switzerland
Red wine consumption and oxidation of
low-density lipoproteins
SIR-There is growing interest in the hypothesis that red
wine phenolics can protect low-density lipoproteins (LDL)
against oxidative modification, thereby reducing the risk of
cardiovascular morbidity. Wine flavonoids inhibit Cu2+-
mediated oxidation of LDL when added in vitro,’ but the
effect of flavonoids eaten with foods is unclear. Although
Kondo and colleagues (Oct 22, p 1152) report that red wine
(Chateau Lagrange, 1989) consumption for two weeks was
associated with an increased resistance of LDL against
oxidative modification, enthusiasm for their hypothesis
should be tempered. We have assessed whether the
consumption of alcohol-poor red wine affects susceptibility
of LDL to Cu2’-mediated oxidative modification.
24 healthy non-smoking normolipidaemic volunteers
consumed white wine for two weeks (baseline period). They
were then randomly assigned to consumption of 550 mL
(about 4-5 glasses) daily of white (Loire, 1993) or red wine
(Italian Chianti Classico, 1991) for 4 weeks (test period),
with stratification for age, sex, and plasma cholesterol
concentration. Before distribution, the alcohol content of
both wines was reduced to 3% by evaporation at 35&deg;C
without affecting the flavonoid concentrations of the wines.
Subjects followed a flavonoid-poor diet and abstained from
tea and red wine. Subjects were not taking vitamin or
mineral supplements. Fasting blood samples were obtained
on two days at the end of the baseline period and of the test
period, to determine the susceptibility of LDL to oxidation
(variation coefficients <3%). Plasma samples were stored at
- 80&deg;C under nitrogen after the addition of saccharose to
stabilise the lipoproteins. Lag times and oxidation rates,
M=male, F=female.
Table: Subjects’ details and in-vitro oxidation characteristics
of LDL
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indicating the resistance of LDL against oxidative
modification, were closely similar in both wine groups
(table).
Thus, in contrast with Kondo and colleagues’ findings, in
our hands daily consumption of flavonoid-rich red wine did
not influence the oxidisability of LDL. Variables that might
account for the differences are the use of different brands of
red wine, the ethanol content of red wine as an unwanted
confounding variable, and the analytical precision of the
assay method used. Our findings do not accord with the
proposed beneficial effect of red wine consumption on LDL
oxidation.
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Carcinogenicity of coal-tar shampoo
SiR-van Schooten and colleagues report (Nov 26, p 1505)
the absorption of polycyclic aromatic hydrocarbons and the
excretion of 1-hydroxypyrene (1-OH-P) after application of
a 12-5% coal-tar solution. Coal-tar solution is derived from
crude coal tar which contains polycyclic aromatic
hydrocarbons. The level of urinary excretion of the
polycyclic aromatic hydrocarbons metabolite 1-OH-P has
been used as a measure of occupational exposure to these
hydrocarbons and a reflection of the degree of dermal
absorption of them from coal-tar-containing products.
van Schooten and co-workers examined the urinary
excretion of 1-OH-P in 11 volunteers in the Netherlands for
two days after a single hairwash consisting of two
applications for 20 s each with a coal-tar shampoo. A peak
urinary 1-OH-P of about 13 nmol was shown at about 24 h
after application during the two-day period of this study.
According to their findings, this level of urinary 1-OH-P is
equivalent to that recorded in occupationally exposed coke-
oven workers. Details of coal tar exposure, medical
condition, occupation, and smoking status of the subjects
tested were not noted. The results were for a limited number
of subjects and a small control group.
The potential carcinogenic properties of therapeutic coal-
tar-containing products and the risks associated with their
use have previously been evaluated. The relevance of van
Schooten’s results should be assessed in relation to data for
the potential carcinogenicity of coal-tar shampoos. In the
USA coal tar is monographed by the Food and Drug
Administration (FDA) as category I GRAS/E (generally
regarded as safe and effective) for over-the-counter use in
the treatment of dandruff, seborrhoea, and psoriasis.’ A risk
analysis of the potential carcinogenicity of a coal-tar-
containing solution shampoo would be based on several
clinical variables that are specific to this mode of exposure
and which differ from those of occupationally-exposed
workers. These factors include the amount of shampoo used,
the duration and extent of application, the number of
applications per use, the frequency of application, the
residual amount left on the scalp, and the coal tar absorption
rate and amount.
Hansen and co-workers’ results2 suggest that raised
urinary 1-OH-P concentrations might not persist after
continuous exposure to polycyclic aromatic hydrocarbons.
In two patients treated once a day with coal-tar pitch
covering more than 50% of the skin, the concentration of
urinary 1-OH-P was increased about 100-fold. However,
after three weeks of continuous daily coal-tar treatments,
urinary excretion of 1-OH-P returned to baseline values.
The long-term effects on urinary excretion of a coal-tar
shampoo such as used by van Schooten and colleagues
would be of interest.
Data that specifically link coal tar polycyclic aromatic
hydrocarbons components such as benzo(a)pyrene to an
increased risk for cancer in exposed populations are
inadequate. Although lung cancer has resulted from
polycyclic aromatic hydrocarbons exposure such as cigarette
smoke, roofing tar, and coke-oven emissions, it cannot be
concluded that benzo(a)pyrene is the causative agent.3 In
particular, there are no reported studies specifically linking
use of coal-tar-solution-containing shampoos to an increased
risk of cancer. Current evidence suggests that the
carcinogenic risk of coal tar, if it exists, is small. The US
FDA, with respect to labelling, generally warns only of the
risks that are scientifically documented, clinically significant,
and important for the safe and effective use of products by
average consumers.
William J Goldman
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Bird attacks on milk bottles and
campylobacter infection
SIR-Species of campylobacter are the most commonly
reported causes of gastrointestinal disease in the UK.’ The
outstanding feature of campylobacter epidemiology is the
rise in isolations reported by laboratories over a 3-4 week
period in the spring. In Wales the spring peak in 1994 was in
week 21 (ending May 27), with a 3-fold increase in reports
over the preceding 3 weeks (figure). Previous studies in the
UK have identified drinking milk from bottles whose tops
had been pecked by magpies and jackdaws as sources of
infection.2-4 But colleagues still have difficulty in accepting
this explanation. To find out if birds pecking milk bottle
tops is still a significant public health problem in Wales we
monitored human campylobacter infections from April to
June, 1994, in collaboration with environmental health
departments. 21 departments agreed to ask questions about
milk bottle attacks as part of routine interviews with cases.
Between April 1 and June 30, 657 cases were reported to
these departments by laboratories; 551 (84%) of patients
were interviewed and 93 (17%) reported drinking milk from
bottles attacked by birds in the week before onset (table). In
*Of those interviewed.
Table: Results of enhanced surveillance of campylobacter
infection in Wales (1994)
